問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberCERL080ATW12
Active

2020-12-01 - 2025-12-31

Phase IV

Recruiting3

Terminated3

ICD-10E10.21

Type 1 diabetes mellitus with diabetic nephropathy

ICD-10E11.21

Type 2 diabetes mellitus with diabetic nephropathy

ICD-10N16

Renal tubulo-interstitial disorders in diseases classified elsewhere

ICD-9583.81

Nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere

  • Trial Applicant

    NOVARTIS (TAIWAN) CO., LTD.

  • Sponsor

  • Trial scale

    Taiwan Multiple Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator CHIEH-YU SHEN Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Shue-Fen Lo Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 鄭添財 Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 吳詹永嬌 Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator WEN-NAN HUANG Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 羅淑芬 Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    64 participants

  • Global

    NA participants